Home › Biotech with unproven Alzheimer's drug now worth billions
 

Keywords :   


Biotech with unproven Alzheimer's drug now worth billions

2015-06-12 08:42:22| Biotech - Topix.net

Investors are giving Axovant Sciences Ltd. an almost $3 billion valuation after its public-market debut.

Tags: worth drug biotech billions

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »